Scoping Review on Management of Nephrostomy – and Double J-Stent – Associated Infections

Authors

  • Beatriz Oliveira Urology Department, Unidade Local de Saúde de Santo António, Porto, Portugal
  • Marta Magalhães Urology Department, Unidade Local de Saúde de Santo António, Porto, Portugal
  • Nuno Vinagre Urology Department, Unidade Local de Saúde de Santo António, Porto, Portugal
  • Frederico Teves Urology Department, Unidade Local de Saúde de Santo António, Porto, Portugal
  • Avelino Fraga Urology Department, Unidade Local de Saúde de Santo António, Porto, Portugal

DOI:

https://doi.org/10.24915/aup.230

Keywords:

Nephrostomy, Scoping Review, Stents, Urinary TractInfections

Abstract

Catheter-associated urinary tract infections (CA-UTIs) refer to infections related to indwelling urinary catheters and are the main cause of hospital-acquired urinary tract infections. Most literature, including the European Urological Association (EAU) Urological Infections Guidelines, defines CA-UTIs as infections specifically associated with urethral catheters, excluding catheter-associated infections related to percutaneous nephrostomies and double-J stents. As a result, there are limited guidelines for managing these types of infections, namely, on determining when to change or remove the catheter. This is probably due to the scarcity of information, the lack of uniformization in terminology (bacteriuria versus infection) and the low evidence of available studies. This scoping review seeks to map the available evidence on infections associated with percutaneous nephrostomies (PN-UTIs) and double-J stents (DJ-UTIs). The review aims to address if studies provide a clear definition of asymptomatic bacteriuria and stent-associated infections; what are the most common pathogens associated with PN- and DJ-UTIs, and what recommendations are outlined in the literature for managing these infections. We performed this scoping review according to the PRISMA-ScR extension for scoping reviews. The search was made in the databases PubMed/MEDLINE, Scopus and Cochrane Library. We defined the following outcomes for analysis: type of stent, definition of bacteriuria and infection, urine and stent culture methods, pathogens, and information on treatment approach. The search yielded 441 articles, narrowed to 12 based on eligibility, relevance, and currency. Most studies, aside from two systematic reviews, were prospective and retrospective observational cohorts with small sample sizes (median 204 patients) and evidence level 3c. Stent-related infections were defined using inconsistent clinical criteria, with asymptomatic bacteriuria often undefined. Common pathogens included (26%), E. coli Enterococcus faecalis Pseudomonas aeruginosa (17%), and (14%). Urine cultures are typically performed using midstream urine samples, while stent cultures are primarily conducted for research purposes. Treatment approaches in the literature are highly variable. The management of catheters for source control is a topic with limited discussion, and recommendations vary, including stent replacement either before or after starting empirical antibiotics. A standardized treatment protocol remains to be established.

Downloads

Download data is not yet available.

References

Bonkat G, Kranz J, Cai T. EAU Guidelines on Urological Infections. EAU Guidelines Edn presented at the EAU Annual Congress Madrid, Spain. 2025.

Gould C V, Umscheid CA, Rajender, Agarwal K, Kurtz G, Pegues DA. Guideline for Prevention of Catheter-Associated Urinary Tract Infections. Bethesda: Centers for Disease Control and Prevention (CDC); 2009 [Updated June 6, 2019] Available: https://www.cdc.gov/infection-control/hcp/cauti/index.html

Valée M, Bey E, Bouiller K, le Goux C, Pimple R, Tourret-Arnaud J, et al. Epidemiology and risk factors for ureteral stent-associated urinary tract infections in non-transplanted renal patients: a systematic review of the literature. World J Urol. 2021;39:3845-60. doi:10.1007/s00345-021-03693-7

Kozyrakis D, Perikleous S, Chatzistamou SE, Kateris D, Soukias G, Karatzas A, et al. Is There a Role for Double J Stent Culture in Contemporary Urology? Urol Int. 2018;100:203-8. doi:10.1159/000486798

De Waele JJ. Importance of timely and adequate source control in sepsis and septic shock. Journal of Intensive Medicine. 2024;4:281-6. doi:10.1016/j.jointm.2024.01.002

Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-247. doi:10.1007/s00134-021-06506-y

Scotland KB, Lo J, Grgic T, Lange D. Ureteral stent-associated infection and sepsis: pathogenesis and prevention: a review. Biofouling. 2019;35:117-27. doi:10.1080/08927014.2018.1562549

Lange D, Bidnur S, Hoag N, Chew BH. Ureteral stent-associated complications-where we are and where we are going. Nat Rev Urol. 2015;12:17-25. doi:10.1038/nrurol.2014.340

Miller DL, O’Grady NP. Guidelines for the prevention of intravascular catheter-related infections: Recommendations relevant to interventional radiology for venous catheter placement and maintenance. J Vasc Intervent Radiol. 2012;23:997-1007. doi:10.1016/j.jvir.2012.04.023

Aydin HR, Irkilata L, Aydin M, Gorgun S, Demirel HC, Adamur S, et al. Incidence of bacterial colonisation after indwelling of double-J ureteral stent. Arch Ital Urol Androl. 2015;87:291-4. doi:10.4081/aiua.2015.4.291

Lojanapiwati B. Colonization of internal ureteral stent and bacteriuria. World J Urol. 2006;24:681-3. doi:10.1007/s00345-006-0135-6

Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology. 2003;62:214-7. doi:10.1016/S0090-4295(03)00325-X

Akay AF, Alfay U, Gedik A, Sahin H, Bircan MK. Risk factors for lower urinary tract infection and bacterial stent colonization in patients with a double J ureteral stent. Int Urol Nephrol. 2007;39:95-8. doi:10.1007/s11255-006-9150-1

Kar M, Dubey A, Patel SS, Siddiqui T, Ghoshal U, Sahu C. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent and percutaneous nephrostomy tube. J Glob Infect Dis. 2022;14:75-80. doi:10.4103/jgid.jgid_276_21

Paul R. State of the globe: Rising antimicrobial resistance of pathogens in urinary tract infection. J Glob Infect Dis. 2018;10:117-8. doi:10.4103/jgid.jgid_104_17

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169:467-73. doi:10.7326/M18-0850

Kim JY, Yeo JK, Park MG, Sung LIH, Cho DY, Yu JH. Determination of microbiological characteristics and risk factors associated with bacteriuria and symptomatic urinary tract infection in patients with retained ureteral stents: an observational study. Transl Androl Urol. 2023;12:19-32. doi:10.21037/tau-22-331

Maramara B, Lobo Z, Psevdos G. Epidemiology of Nephrostomy Tube-Related Urinary Tract Infections Among US Veterans. Infect Dis Clin Pract. 2018;26.

Bahu R, Chaffari AM, Hachem RY, Ahrar K, Shomail W, El Zakhem A, et al. Nephrostomy tube related pyelonephritis in patients with cancer: Epidemiology, infection rate and risk factors. J Urol. 2013;189:130-5. doi:10.1016/j.juro.2012.08.094

Li Y, Jiang L, Luo S, Hu D, Zhao X, Zhao G, et al. Analysis of Characteristics, Pathogens and Drug Resistance of Urinary Tract Infection Associated with Long-Term Indwelling Double-J Stent. Infect Drug Resist. 2023;16:2089-96. doi:10.2147/IDR.S392867

Jiang G, Li J, Long H, Qiulin C, Jin R, Yaodong Y, et al. Study on risk factors, bacterial species, and drug resistance of acute pyelonephritis associated with ureteral stent after percutaneous nephrolithotomy. Eur J Clin Microbiol Infect Dis. 2021;40:707-13. doi:10.1007/s10096-020-04050-z

Bailly B, Lecheneaut M, Gbaguidi-Haore H, Chirotze C, Kleinclauss F, Bouiller K. Epidemiology and risk factors for febrile ureteral stent-associated urinary tract infections: A prospective observational cohort study. J Infect. 2023;87:12-7. doi:10.1016/j.jinf.2023.04.021

Souhail B, Charlot P, Deroudilhe G, Cobleniz Y, Pierquet G, Gimel P, et al. Urinary tract infection and antibiotic use around ureteral stent insertion for urolithiasis. Eur J Clin Microbiol Infect Dis. 2020;39:2077-83. doi:10.1007/s10096-020-03953-1/Published

Mert D, Iskender G, Kolgelier S, Ertek M. Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients. Medicine. 2023;102-E33002. doi:10.1097/MD.0000000000033002

Szvalb AD, El Haddad H, Rolston KV, Sabir SH, Jiang Y, Raad II, et al. Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection. 2019;47:239-45. doi:10.1007/s15010-018-1245-y.

Chen SJ, Huang CP, Chiu KY, Chen HY, Lu-Ting, Chen YH, et al. Association of acute pyelonephritis with double-J ureteral stenting: a nationwide population-based case control study. Scand J Urol. 2021;55:61-6. doi:10.1080/21681805.2020.1817142.

Siddiq DM, Darouiche RO. Infectious complications associated with percutaneous nephrostomy catheters: do we know enough? Int J Artif Organs. 2012;35:898-907. doi:10.5301/ijao.5000146.

Zhang JM, Liu J, Wang K, Zhang X, Zhao T, Luo HM. Observations of Bacterial Biofilm on Ureteral Stent and Studies on the Distribution of Pathogenic Bacteria and Drug Resistance. Urol Int. 2018;101:320-6. doi:10.1159/000490621

Fésüs A, Matuz M, Papfaki E, Hambalek H, Ruzsa R, Tánczos B, et al. Evaluation of the Diagnosis and Antibiotic Prescription Pattern in Patients Hospitalized with Urinary Tract Infections: Single-Center Study from a University-Affiliated Hospital. Antibiotics. 2023;12:1689. doi:10.3390/antibiotics12121689.

Khalawi F, Arain S, Thorakkatti SA. Appropriateness of antibiotic prescribing for urinary tract infection in the emergency department of a tertiary care hospital. Clin Epidemiol Glob Health. 2024;27. doi:10.1016/j.cegh.2024.101608

Schmiemann G, Hoffmann F, Hamprecht A, Jobski K. Patterns and trends of antibacterial treatment in patients with urinary tract infections, 2015–2019: an analysis of health insurance data. BMC Primary Care. 2022;23. doi:10.1186/s12875-022-01816-6

Published

2025-11-07

Issue

Section

Original Article